SystÃ¨me cardiovasculaire - MedQual

More documents

Recommendations

Info

189. Anonymous. Do statins have a role in primary prevention Therapeutics Letter april-june 2003;48. www.ti.ubc.ca 190. Pignone M. Primary prevention: dyslipidaemia. BMJ Clin Evid [online] 2006 [cited Dec 2007]. www.clinicalevidence.com 191. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22. 192. Heart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20,536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004;363:757-767. 193. Johnston SC. Cholesterol lowering with simvastatin reduced stroke in patients with, or at risk for, vascular disease. Comment on: Heart Protection Study Collaborative Group. Effects of cholesterollowering with simvastatin on stroke and other major vascular events in 20,536 people with cerebrovascular disease or other high-risk conditions. ACP Journal Club 2004;141:32. 194. Anonymous. Prendre en charge les accidents vasculaires cérébraux. La Revue Prescrire 2005;262:436- 442. 195. Anonymous. Drugs to prevent vascular events after stroke. Drug Ther Bull 2005;43:53-6. 196. SPARCL investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-559. 197. Special Report: The efficacy and safety of statins in the elderly. TEC 2007;21:1-29. 198. Risk estimation and the prevention of cardiovascular disease. SIGN. Feb 2007. www.sign.ac.uk 199. The FIELD study investigators. Effects of long term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised copntrolled trial. Lancet 2005;366:1849-1861. 200. Anonymous. Ezetemibe: a new cholesterol-lowering drug. DTB 2004;42:65-67. 201. Laine C,Goldmann D, Wilson JF. Peripheral Arterial Disease.Ann Intern Med 2007; 146: ITC3-13. 202. ACC/AHA 2005 Guidelines for the management of patients with peripheral arterial disease [Lower extremity, renal, mesenteric, and abdominal aortic]: Executive summary. JACC 2006;47:1239-1312. 203. Cassar K. Peripheral arterial disease. BMJ Clin Evid [online] 2007 [cited Dec 2007]. www.clinicalevidence.com 204. Bartelink M, Stoffers H, Boutens E et al. NHG-Standaard Perifeer arterieel vaatlijden Huisarts Wet 2003;46: 848-58. http://nhg.artsennet.nl 205. SIGN. Diagnosis and management of peripheral vascular disease. Draft 1.1/ October 2004. www.sign.ac.uk 206. Anonymous. Clopidogrel. Geneesmiddelenbulletin 1999;33:8. 207. Anonymous. Aspirine ou clopidogrel en première intention La Revue Prescrire 2002;22:76. 208. Heart Protection Study Group. Randomised trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peropheral arterial disease and other high risk conditions. J Vasc Surg 2007;45:645-654. 209. De Backer T, Vander Stichele R, Bogaert M. Buflomedil for intermittent claudication. Cochrane Database of Systematic Reviews 2000, Issue 2. Art. No.: CD000988. DOI: 10.1002/14651858.CD000988. 210. Martinez M, Bonfill X, Moreno R et al. Phlebotonics for venous insufficiency. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD003229. DOI: 10.1002/14651858.CD003229.pub2. 211. Pittler M, ernst E. Horse chestnut seed extract for chronic venous insufficiency. Cochrane Database Systematic Review 2006, Issue 1. Art. No.: CD003230. DOI: 10.1002/14651858.CD003230.pub3. 212. Simon D, Dix F, McCollum C. Management of venous leg ulcers. BMJ 2004;328:1358-1362. 213. Schweitzer B, Doorenbosch J, Glotzbach R et al. NHG-Standaard Ulcus cruris venosum. http://nhg.artsennet.nl 214. Jull A, Waters J, Arroll B. Pentoxifylline for treatment of venous leg ulcers: a systematic review. Lancet 2002;359:1550-4. 215. Dale J, Ruckley V, Harper R et al. Randomised, double blind placebo controlled trial of pentoxifylline in the treatment of venous leg ulcers. BMJ 1999;319:875-8. 216. Van Weert H, Dolan G Wichers Iet al. Oppervlakkige tromboflebitis verhoogt het risico op een diepe veneuze trombose. Huisarts Wet 20006;49:414-417. 217. Di Nisio M, Middeldorp S, Wichers I. Treatment for superficial trombophlebitis of the leg. Cochrane Database of Systematic Reviews. 2007, Issue 2. Art. No.: CD004982. DOI: 10.1002/14651858.CD004982.pub3. 40 Système <strong>cardiovasculaire</strong>
Système <strong>cardiovasculaire</strong> 41
Page 1 and 2: Système cardiovasculaire Sélectio
Page 3 and 4: Une méta-analyse montre un intér
Page 5 and 6: invalidant (avec une bonne fonction
Page 7 and 8: Il existe des études randomisées
Page 9 and 10: vasculaire), 1 AVC ischémique peut
Page 11 and 12: côté, montre par ailleurs des pro
Page 13 and 14: L’acide tranexamique semble effic
Page 15 and 16: l’utilisation de clopidogrel appo
Page 17 and 18: Referenties 1. Management of chroni
Page 19 and 20: 56. Pfisterer M, Buser P, Osswald S
Page 21 and 22: 111. Julius S et al Outcomes in hyp
Page 23: 165. Roderick P, Ferris G, Wilson K
Page 27 and 28: Interactions + ciclosporine: le car
Page 29 and 30: Système cardiovasculaire 45
Page 31 and 32: Interactions + insuline, hypoglycé
Page 33 and 34: Interactions + insuline, hypoglycé
Page 37 and 38: Précautions d’utilisation • en
Page 39 and 40: Fiche technique Prescription en DCI
Page 41 and 42: Précautions d’utilisation • en
Page 45 and 46: Interactions + diurétiques, cortic
Page 47 and 48: Effets indésirables • troubles d
Page 55 and 56: Interactions + le risque d’hémor
Page 59 and 60: • chirurgicale récente,…). Si

SystÃ¨me cardiovasculaire - MedQual

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?